Real-time enrollment status for this lung cancer clinical trial
Current Status
Active, Not Recruiting
Checked: April 17, 2026 at 2:25 AM UTC
| NCT Number | NCT06008093 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 280 participants |
| Active Locations | 105 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | March 30, 2026 (2 weeks ago) |
As of April 17, 2026: Clinical trial NCT06008093 is currently active_not_recruiting participants. This clinical trial study for lung cancer is not currently accepting new participants at 105 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06008093 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 105 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06008093 was last updated 2 weeks ago (March 30, 2026). HelloStudys verifies this status automatically.